Atezolizumab added to pertuzumab plus trastuzumab in HER2+ metastatic breast cancer
The addition of atezolizumab to pertuzumab plus high-dose trastuzumab doesn’t improve brain metastases in HER2+ breast cancer patients
Day: October 14, 2024
The addition of atezolizumab to pertuzumab plus high-dose trastuzumab doesn’t improve brain metastases in HER2+ breast cancer patients